[Dutch guideline for cardiovascular risk management: a consensus model].

Abstract

This commentary concerns two major aspects of the guideline, which was revised in 2011 and seems to us the result of a consensus model. The first aspect, namely, of age in relation to cardiovascular risk stratification and the indication that recent studies show that treatment of hypertension of both very old and young people should be considered, is discussed. The second aspect discussed in this commentary, regarding hyperlipidaemia in obesity and diabetes, concerns the argument that apolipoprotein B-100 level or non-HDL cholesterol should specifically be measured for screening and treatment targets.

• Authors: A A Bram Kroon
• Journal: Nederlands tijdschrift voor geneeskunde (Ned Tijdschr Geneeskd) Vol. 156 Issue 36 Pg. A5196 ( 2012) ISSN: 1876-8784 [Electronic] Netherlands
• Vernacular Title: Richtlijn cardiovasculair risicomanagement: een poldermodel.
• PMID: 22951135 (Publication Type: Journal Article, Comment)

Chemical References

• Antihypertensive Agents
• Cardiovascular Agents

Topics

• Antihypertensive Agents (therapeutic use)
• Cardiovascular Agents (therapeutic use)
• Cardiovascular Diseases (prevention & control)
• Humans
• Practice Guidelines as Topic
• Risk Management